Read this article in:
In a first, Lausanne, Switzerland-based medical device company Comphya announced on Monday the successful implantation of a high-tech, battery-powered device to restore erectile function.
The company has developed CaverSTIM, the first implantable device to address erectile dysfunction in patients who do not respond to oral medications.
This group includes patients who have suffered spinal cord injuries and those who have undergone prostate removal surgery, also known as post-prostatectomy patients.
The successful transplant took place at the Royal Melbourne Hospital (RMHin Melbourne, Australia.